S. Fojo

发表

An ATP-binding cassette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the Sitosterolemia locus

L. Schriml, A. Remaley, R. Allikmets, 2001, Cytogenetic and Genome Research.

Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.

R. Gregg, H. Brewer, D. Wilson, 1988, Journal of lipid research.

Apolipoproteins and lipoproteins in human plasma: an overview.

R. Gregg, H. Brewer, J. Hoeg, 1988, Clinical chemistry.

Mevinolin and Neomycin in the Treatment of Type II Hyperlipoproteinemia

K. Bailey, H. Brewer, J. Hoeg, 1987 .

The molecular biology of human apoA-I, apoA-II, apoC-II and apoB.

H. Brewer, K. Lackner, J. Monge, 1986, Advances in experimental medicine and biology.

Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome.

H. Brewer, J. Brunzell, S. Skarlatos, 1991, The Journal of biological chemistry.

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C‐II

H. Brewer, S. Fojo, 1992, Journal of internal medicine.

Homozygous hypobetalipoproteinemia: transcriptional regulation and 5'-flanking sequence analysis in an apolipoprotein B deficiency state.

R. Gregg, H. Brewer, J. Hoeg, 1989, Biochimica et biophysica acta.

Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.

H. Brewer, J. Brunzell, L. Previato, 1990, Proceedings of the National Academy of Sciences of the United States of America.

An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II.

H. Brewer, J. Truffert, C. Parrott, 1989, Journal of Biological Chemistry.

Analysis of the apoC-II gene in apoC-II deficient patients.

R. Gregg, H. Brewer, D. Sprecher, 1984, Biochemical and biophysical research communications.

Absence of triglyceride accumulation in lipoprotein lipase-deficient human monocyte-macrophages incubated with human very low density lipoprotein.

H. Brewer, S. Skarlatos, H. Kruth, 1993, The Journal of clinical endocrinology and metabolism.

The isolation and characterization of a colony stimulating factor from human lung.

A. Yunis, M. Wu, S. Fojo, 1977, Biochimica et biophysica acta.

Apolipoprotein C‐ll deficiency syndrome due to apo C‐IIHamburg: clinical and biochemical features and Hphl restriction enzyme polymorphism

H. Brewer, U. Beisiegel, F. Beil, 1992, European journal of clinical investigation.

Purification and characterization of a colony stimulating factor from human lung.

A. Yunis, M. Wu, S. Fojo, 1978, Biochemistry.

A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency.

H. Brewer, C. Gabelli, G. Baggio, 1989, The Journal of clinical investigation.

The Molecular Basis of ApoC-II Deficiency

R. Gregg, H. Brewer, A. Stalenhoef, 1989 .

Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency.

R. Gregg, H. Brewer, U. Beisiegel, 1988, The Journal of clinical investigation.

Apolipoprotein C-II deficiency: identification of a structural variant ApoC-II Padova.

R. Gregg, H. Brewer, C. Gabelli, 1988, Biochemical and biophysical research communications.

Genomic Structure, Biosynthesis, and Processing of Preproapolipoprotein C-II

H. Brewer, J. Hoeg, D. Sprecher, 1987 .

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.

K. Bailey, R. Gregg, J. Hoeg, 1986, The American journal of cardiology.

The localization of the gene for apolipoprotein C-II to chromosome 19.

S. Naylor, H. Brewer, A. Sakaguchi, 1984, Biochemical and biophysical research communications.

Human preproapolipoprotein C-II. Analysis of major plasma isoforms.

H. Brewer, J. Hoeg, D. Sprecher, 1986, The Journal of biological chemistry.

Apolipoprotein C-II Deficiency Syndrome: New Insights into the Molecular Mechanism Leading to the Disease in the Apo C-II Padova Kindred

G. Crepaldi, L. Previato, C. Gabelli, 1989 .

A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II.

R. Gregg, H. Brewer, A. Stalenhoef, 1988, The Journal of biological chemistry.

Molecular genetics of apoC-II and lipoprotein lipase deficiency.

H. Brewer, A. Stalenhoef, J. Brunzell, 1991, Advances in experimental medicine and biology.

Human apolipoprotein C-II: complete nucleic acid sequence of preapolipoprotein C-II.

H. Brewer, S. Law, S. Fojo, 1984, Proceedings of the National Academy of Sciences of the United States of America.

The molecular defects in lipoprotein lipase deficient patients

H. Brewer, H. Dichek, O. Beg, 1992, European Journal of Epidemiology.

Adrenocortical Function in Type II Hyperlipoproteinemic Patients Treated with Lovastatin (Mevinolin)

K. Bailey, H. Brewer, K. Lackner, 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The human preproapolipoprotein C‐II gene

S. Law, S. Fojo, Silvia S. Fojo, 1987, FEBS letters.

A naturally occurring mutation at the second base of codon asparagine 43 in the proposed N-linked glycosylation site of human lipoprotein lipase: in vivo evidence that asparagine 43 is essential for catalysis and secretion.

H. Brewer, H. Inadera, J. Kobayashi, 1994, Biochemical and biophysical research communications.

MARROW COLONY STIMULATING FACTOR FROM HUMAN LUNG

A. Yunis, M. Wu, S. Fojo, 1978 .